Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a8fb1456312aa7998c552f43f015e6bc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D275-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D275-06 |
filingDate |
2021-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11b003259158a96398445d8ea25edf83 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25fae470c38f7d26de5471f932022dfe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858506e546bd635e1e4760b03caf50b7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4857fc649c0397aef53c24e1f1cf27f8 |
publicationDate |
2021-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2021163442-A1 |
titleOfInvention |
Crystalline forms of lenalidomide |
abstract |
The present invention provides for novel co-crystals of lenalidomide. The present invention particularly provides for novel cocrystals of lenalidomide with Resorcinol, Methyl paraben and Saccharin. The present invention also provides for the processes for the production of cocrystals of lenalidomide with Resorcinol, Methyl paraben and Saccharin. The present invention further provides for processes for the preparation of crystalline anhydrous lenalidomide Form IV. |
priorityDate |
2017-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |